3
Views
17
CrossRef citations to date
0
Altmetric
Original Articles

Are incremental doses of amphotericin B required for the treatment of visceral leishmaniasis?

, , &
Pages 365-370 | Received 23 Feb 1994, Accepted 04 Mar 1994, Published online: 15 Nov 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

S. Sundar, A. K. Goyal, D. K. More, M. K. Singh & H. W. Murray. (1998) Treatment of antimony-unresponsive Indian visceral leishmaniasis with ultra-short courses of amphotericin-B-lipid complex. Annals of Tropical Medicine & Parasitology 92:7, pages 755-764.
Read now
C. P. Thakur, S. Narain, N. Kumar, S. M. Hassan, D. K. Jha & A. Kumar. (1997) Amphotericin B is superior to sodium antimony gluconate in the treatment of Indian post-kala-azar dermal leishmaniasis. Annals of Tropical Medicine & Parasitology 91:6, pages 611-616.
Read now

Articles from other publishers (14)

Naomi E. Aronson & Alan J. Magill. 2020. Hunter's Tropical Medicine and Emerging Infectious Diseases. Hunter's Tropical Medicine and Emerging Infectious Diseases 776 798 .
Om Prakash Singh, Bhawana Singh, Jaya Chakravarty & Shyam Sundar. (2016) Current challenges in treatment options for visceral leishmaniasis in India: a public health perspective. Infectious Diseases of Poverty 5:1.
Crossref
Colette L. M. van Hees & Ben Naafs. 2016. Antibiotic and Antifungal Therapies in Dermatology. Antibiotic and Antifungal Therapies in Dermatology 291 338 .
Caspar J. Hodiamont, Piet A. Kager, Aldert Bart, Henry J. C. de Vries, Pieter P. A. M. van Thiel, Tjalling Leenstra, Peter J. de Vries, Michèle van Vugt, Martin P. Grobusch & Tom van Gool. (2014) Species-Directed Therapy for Leishmaniasis in Returning Travellers: A Comprehensive Guide. PLoS Neglected Tropical Diseases 8:5, pages e2832.
Crossref
Begoña Monge-Maillo & Rogelio López-Vélez. (2013) Therapeutic Options for Visceral Leishmaniasis. Drugs 73:17, pages 1863-1888.
Crossref
Alan J Magill. 2013. Hunter's Tropical Medicine and Emerging Infectious Disease. Hunter's Tropical Medicine and Emerging Infectious Disease 739 760 .
Didier BessisJean-Pierre Dedet. 2008. Manifestations dermatologiques des maladies infectieuses, métaboliques et toxiques. Manifestations dermatologiques des maladies infectieuses, métaboliques et toxiques 199 217 .
Piero L Olliaro, Philippe J Guerin, Sibylle Gerstl, Astrid Aga Haaskjold, John-Arne Rottingen & Shyam Sundar. (2005) Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980–2004. The Lancet Infectious Diseases 5:12, pages 763-774.
Crossref
Suman Gupta, Suman Tiwari, A.P Bhaduri & G.K Jain. (2002) Anilino-(2-bromophenyl) acetonitrile: a promising orally effective antileishmanial agent. Acta Tropica 84:3, pages 165-173.
Crossref
C.P. Thakur. (2001) A single high dose treatment of kala-azar with Ambisome (amphotericin B lipid complex): a pilot study. International Journal of Antimicrobial Agents 17:1, pages 67-70.
Crossref
Shyam Sundar, Lal B. Gupta, Vishal Rastogi, Gaurav Agrawal & Henry W. Murray. (2000) Short-course, cost-effective treatment with amphotericin B-fat emulsion cures visceral leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 94:2, pages 200-204.
Crossref
C.P. Thakur, R.K. Singh, S.M. Hassan, R. Kumar, S. Narain & Ashok Kumar. (1999) Amphotericin B deoxycholate treatment of visceral leishmaniasis with newer modes of administration and precautions: a study of 938 cases. Transactions of the Royal Society of Tropical Medicine and Hygiene 93:3, pages 319-323.
Crossref
Jean-Pierre Gangneux, Annie Sulahian, Yves Jean-François Garin & Francis Derouin. (1996) Lipid formulations of amphotericin B in the treatment of experimental visceral leishmaniasis due to Leishmania infantum. Transactions of the Royal Society of Tropical Medicine and Hygiene 90:5, pages 574-577.
Crossref
J P GangneuxA SulahianY J GarinR FarinottiF Derouin. (1996) Therapy of visceral leishmaniasis due to Leishmania infantum: experimental assessment of efficacy of AmBisome. Antimicrobial Agents and Chemotherapy 40:5, pages 1214-1218.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.